MYR 4.33
(-1.59%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 338.98 Million MYR | 2.64% |
2022 | 330.28 Million MYR | 10.41% |
2021 | 299.15 Million MYR | 18.46% |
2020 | 252.54 Million MYR | -0.27% |
2019 | 253.23 Million MYR | 2.76% |
2018 | 246.44 Million MYR | 1.49% |
2017 | 242.82 Million MYR | -3.69% |
2016 | 252.12 Million MYR | -0.61% |
2015 | 253.66 Million MYR | -0.13% |
2014 | 253.99 Million MYR | -6.69% |
2013 | 272.2 Million MYR | 3.38% |
2012 | 263.3 Million MYR | 2.25% |
2011 | 257.51 Million MYR | 4.17% |
2010 | 247.21 Million MYR | 1.9% |
2009 | 242.59 Million MYR | 23.42% |
2008 | 196.56 Million MYR | 78.46% |
2007 | 110.14 Million MYR | 24.53% |
2006 | 88.45 Million MYR | 13.52% |
2005 | 77.91 Million MYR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 Q4 | 338.98 Million MYR | 7.45% |
2023 Q2 | 325.8 Million MYR | -5.01% |
2023 Q3 | 315.47 Million MYR | -3.17% |
2023 FY | 336.64 Million MYR | 1.93% |
2023 Q1 | 342.98 Million MYR | 3.85% |
2022 FY | 330.28 Million MYR | 10.41% |
2022 Q4 | 330.28 Million MYR | 7.15% |
2022 Q3 | 308.24 Million MYR | -1.57% |
2022 Q2 | 313.16 Million MYR | -4.3% |
2022 Q1 | 327.23 Million MYR | 9.39% |
2021 Q2 | 269.99 Million MYR | -0.14% |
2021 Q4 | 299.15 Million MYR | 11.68% |
2021 Q3 | 267.86 Million MYR | -0.79% |
2021 FY | 299.15 Million MYR | 18.46% |
2021 Q1 | 270.36 Million MYR | 7.06% |
2020 Q3 | 244.18 Million MYR | 1.26% |
2020 FY | 252.54 Million MYR | -0.27% |
2020 Q1 | 252.38 Million MYR | -0.34% |
2020 Q2 | 241.15 Million MYR | -4.45% |
2020 Q4 | 252.54 Million MYR | 3.42% |
2019 Q4 | 253.23 Million MYR | 2.86% |
2019 FY | 253.23 Million MYR | 2.76% |
2019 Q1 | 243.64 Million MYR | -1.14% |
2019 Q2 | 244.85 Million MYR | 0.5% |
2019 Q3 | 246.2 Million MYR | 0.55% |
2018 Q4 | 246.44 Million MYR | 0.65% |
2018 FY | 246.44 Million MYR | 1.49% |
2018 Q3 | 244.85 Million MYR | -1.17% |
2018 Q2 | 247.76 Million MYR | 1.23% |
2018 Q1 | 244.74 Million MYR | 0.79% |
2017 FY | 242.82 Million MYR | -3.69% |
2017 Q4 | 242.82 Million MYR | -1.93% |
2017 Q1 | 242.94 Million MYR | -3.64% |
2017 Q2 | 245.77 Million MYR | 1.16% |
2017 Q3 | 247.59 Million MYR | 0.74% |
2016 Q4 | 252.12 Million MYR | -1.5% |
2016 FY | 252.12 Million MYR | -0.61% |
2016 Q1 | 245.95 Million MYR | -3.04% |
2016 Q2 | 254.16 Million MYR | 3.34% |
2016 Q3 | 255.97 Million MYR | 0.71% |
2015 Q3 | 256.97 Million MYR | -0.29% |
2015 Q4 | 253.66 Million MYR | -1.29% |
2015 Q2 | 257.71 Million MYR | -0.2% |
2015 Q1 | 258.24 Million MYR | 1.67% |
2015 FY | 253.66 Million MYR | -0.13% |
2014 Q4 | 253.99 Million MYR | -4.2% |
2014 FY | 253.99 Million MYR | -6.69% |
2014 Q2 | 262.04 Million MYR | -1.09% |
2014 Q1 | 264.93 Million MYR | -2.67% |
2014 Q3 | 265.12 Million MYR | 1.18% |
2013 Q2 | 264.02 Million MYR | 1.51% |
2013 Q3 | 276.99 Million MYR | 4.91% |
2013 Q4 | 272.2 Million MYR | -1.73% |
2013 FY | 272.2 Million MYR | 3.38% |
2013 Q1 | 260.09 Million MYR | -1.22% |
2012 Q2 | 243.23 Million MYR | -3.64% |
2012 Q4 | 263.3 Million MYR | 6.02% |
2012 FY | 263.3 Million MYR | 2.25% |
2012 Q1 | 252.41 Million MYR | -1.98% |
2012 Q3 | 248.34 Million MYR | 2.1% |
2011 Q4 | 257.51 Million MYR | 2.51% |
2011 Q3 | 251.2 Million MYR | -1.06% |
2011 FY | 257.51 Million MYR | 4.17% |
2011 Q2 | 253.88 Million MYR | 0.0% |
2010 FY | 247.21 Million MYR | 1.9% |
2010 Q3 | 246.42 Million MYR | 0.0% |
2010 Q4 | 247.21 Million MYR | 0.32% |
2009 Q4 | 242.59 Million MYR | 0.0% |
2009 FY | 242.59 Million MYR | 23.42% |
2008 FY | 196.56 Million MYR | 78.46% |
2007 FY | 110.14 Million MYR | 24.53% |
2006 FY | 88.45 Million MYR | 13.52% |
2005 FY | 77.91 Million MYR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Duopharma Biotech Berhad | 1.34 Billion MYR | 74.799% |